There are still lots of open positions. Let's find the one that's right for you.
As a Global Medical Affairs Leader (GMAL) in Cardiovascular, Renal, and Metabolism (CVRM) at AstraZeneca, you will play a pivotal role in shaping the medical strategy for our innovative therapies. This position is part of the Biopharmaceuticals Medical (BPM) team, which is dedicated to ensuring that healthcare decision-makers worldwide have the evidence and confidence they need regarding AstraZeneca therapies. Your work will be centered around providing strategic medical insights and expertise to internal stakeholders, with the ultimate goal of achieving scientific leadership while keeping patients at the core of our mission. In this strategic business role, you will leverage your unique medical expertise and insights from various markets, healthcare professionals, patients, and health systems to develop and execute world-class medical strategies for AstraZeneca medicines. As a key member of the Global Medical Team (GMT), you will act as a strategic partner and leader across the medical enterprise, research and development (R&D), and commercial functions. Your role will serve as a vital link between the Global Product Team (GPT) and Medical teams in regions such as the US, EU-Canada, China, Japan, and other major markets. You will ensure that the needs of marketing company affiliates, healthcare professionals, and patients are recognized in ambitious global product and disease area strategies. Your responsibilities will include delivering outstanding product launches, transforming health systems, conducting practice-defining studies, generating real-world evidence, and accelerating the delivery of AstraZeneca clinical trials. You will be responsible for creating compelling scientific narratives and world-class medical content, shaping evidence needs, and designing clinical studies to differentiate or expand market access for AstraZeneca medicines. Additionally, you will drive an ambitious external engagement agenda, partnering with global thought leaders, societies, health organizations, and health system decision-makers to enhance AstraZeneca's presence in the medical community.